NANTAHALA CAPITAL MANAGEMENT, LLC reported 1 transaction at EVOKE PHARMA INC
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
−148.15K
Price / share
$11.00
Trade value
$1.63M
% of position
Net shares
−148.15K
Net value
-$1.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/17/2025 | J · J | −148.15K | $11.00 | $1.63M | New position | 148.15K | 0.00 |
| Total | −148.15K | -$1.63M | ||||||
Prefunded Warrants
Common Stock
433.96K shares
Shares
−433.96K
Strike price
0.0001
Held after
0.00
Exercisable
—
Series A Common Stock Purchase Warrants
Common Stock
117.02K shares
Shares
−117.02K
Strike price
8.16
Held after
0.00
Exercisable
—
Series C Common Stock Purchase Warrants
Common Stock
117.02K shares
Shares
−117.02K
Strike price
8.16
Held after
0.00
Exercisable
—
Amended Series A Common Stock Purchase Warrants
Common Stock
158.53K shares
Shares
−158.53K
Strike price
0.01
Held after
0.00
Exercisable
—
Amended Series C Common Stock Purchase Warrants
Common Stock
250.63K shares
Shares
−250.63K
Strike price
0.01
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Prefunded Warrants Indirect | Common Stock433.96K shares | 12/17/2025 | J · J | −433.96K | 0.0001 | — | 0.00 |
| Series A Common Stock Purchase Warrants Indirect | Common Stock117.02K shares | 12/17/2025 | J · J | −117.02K | 8.16 | — | 0.00 |
| Series C Common Stock Purchase Warrants Indirect | Common Stock117.02K shares | 12/17/2025 | J · J | −117.02K | 8.16 | — | 0.00 |
| Amended Series A Common Stock Purchase Warrants Indirect | Common Stock158.53K shares | 12/17/2025 | J · J | −158.53K | 0.01 | — | 0.00 |
| Amended Series C Common Stock Purchase Warrants Indirect | Common Stock250.63K shares | 12/17/2025 | J · J | −250.63K | 0.01 | — | 0.00 |